Celularity (CELU) Revenue & Revenue Breakdown


OverviewForecastOwnershipFinancialsChart

Celularity Revenue Highlights


Latest Revenue (Y)

$22.77M

Latest Revenue (Q)

$14.68M

Main Segment (Y)

Product

Celularity Revenue by Period


Celularity Revenue by Year

DateRevenueChange
2023-12-31$22.77M26.68%
2022-12-31$17.98M-15.75%
2021-12-31$21.34M49.43%
2020-12-31$14.28M-32.48%
2019-12-31$21.15M-

Celularity generated $22.77M in revenue during NA 2023, up 26.68% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Celularity Revenue by Quarter

DateRevenueChange
2024-03-31$14.68M21.21%
2023-12-31$12.11M219.92%
2023-09-30$3.79M28.86%
2023-06-30$2.94M-25.34%
2023-03-31$3.94M-4.70%
2022-12-31$4.13M-0.15%
2022-09-30$4.13M9.51%
2022-06-30$3.78M-36.38%
2022-03-31$5.93M22.19%
2021-12-31$4.86M-54.27%
2021-09-30$10.62M232.25%
2021-06-30$3.20M20.19%
2021-03-31$2.66M-17.98%
2020-12-31$3.24M-3.34%
2020-09-30$3.35M-3.37%
2020-06-30$3.47M-17.49%
2020-03-31$4.21M-18.31%
2019-12-31$5.15M100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31--

Celularity generated $14.68M in revenue during Q1 2024, up 21.21% compared to the previous quarter, and up 355.56% compared to the same period a year ago.

Celularity Revenue Breakdown


Celularity Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 23Dec 22Dec 21
License Royalty And Other$5.74M$8.71M$12.01M
Product$13.15M$3.75M$3.80M
Service$5.44M$5.51M$5.52M

Celularity's latest annual revenue breakdown by segment (product or service), as of Dec 23: Product (54.05%), License Royalty And Other (23.59%), and Service (22.37%).

Quarterly Revenue by Product

Product/ServiceMar 24Dec 23Sep 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21
Service$1.29M$5.04M$398.00K$1.45M$899.00K$1.37M$1.28M$1.32M$1.34M
License Royalty And Other$551.00K$3.09M$2.65M$1.85M$5.50M$1.18M$4.00M$2.47M$8.43M
Product$12.84M$12.59M$557.00K$829.00K$812.00K$1.23M$651.00K$1.07M$849.00K

Celularity's latest quarterly revenue breakdown by segment (product or service), as of Mar 24: Product (87.48%), Service (8.77%), and License Royalty And Other (3.75%).

Celularity Revenue Breakdown by Country

Quarterly Revenue by Country

CountryDec 22Sep 22Jun 22Mar 22Dec 21Sep 21
Service$1.45M$899.00K$1.37M$1.28M$1.32M$1.34M
License Royalty And Other$1.85M$5.50M$1.18M$4.00M$2.47M$8.43M
Product$829.00K$812.00K$1.23M$651.00K$1.07M$849.00K

Celularity's latest quarterly revenue breakdown by geography, as of Dec 22: License Royalty And Other (44.78%), Service (35.14%), and Product (20.08%).

Celularity Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
VECTVectivBio$27.34M$676.00K
CELUCelularity$22.77M$14.68M
SONNSonnet BioTherapeutics$147.81K-
AVROAVROBIO--
CNSPCNS Pharmaceuticals--
ZVSAZyVersa Therapeutics--
IMMXImmix Biopharma--
HEPAHepion Pharmaceuticals--
EFTReFFECTOR Therapeutics--

CELU Revenue FAQ


Celularity's yearly revenue for 2023 was $22.77M, representing an increase of 26.68% compared to 2022. The company's yearly revenue for 2022 was $17.98M, representing a decrease of -15.75% compared to 2021. CELU's yearly revenue for 2021 was $21.34M, representing an increase of 49.43% compared to 2020.

Celularity's quarterly revenue for Q1 2024 was $14.68M, a 21.21% increase from the previous quarter (Q4 2023), and a 273.09% increase year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $12.11M, a 219.92% increase from the previous quarter (Q3 2023), and a 193.34% increase year-over-year (Q4 2022). CELU's quarterly revenue for Q3 2023 was $3.79M, a 28.86% increase from the previous quarter (Q2 2023), and a -8.44% decrease year-over-year (Q3 2022).

Celularity's revenue growth rate for the last 3 years (2021-2023) was 6.73%, and for the last 5 years (2019-2023) was 7.68%.

Celularity's revenue streams in c 23 are License Royalty And Other, Product, and Service. License Royalty And Other generated $5.74M in revenue, accounting 23.59% of the company's total revenue, down -34.15% year-over-year. Product generated $13.15M in revenue, accounting 54.05% of the company's total revenue, up 250.73% year-over-year. Service generated $5.44M in revenue, accounting 22.37% of the company's total revenue, down -1.29% year-over-year.

For the fiscal year ending Dec 23, the largest source of revenue of Celularity was Product. This segment made a revenue of $13.15M, representing 54.05% of the company's total revenue.